Active substance
Desoximetasone
- US FDA 40
- Health Canada 4
- US price lines 11
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TOPICORT | 0.05% | ointment · topical | TARO | Prescription | 17 Jan 1985 |
| TOPICORT | 0.25% | cream · topical | TARO | Prescription | 29 Nov 1990 |
| TOPICORT | 0.05% | cream · topical | TARO | Prescription | 30 Nov 1990 |
| TOPICORT | 0.05% | gel · topical | TARO | Prescription | 14 Jul 1998 |
| DESOXIMETASONE | 0.25% | cream · topical | PADAGIS ISRAEL | Prescription | 1 Jul 2003 |
| DESOXIMETASONE | 0.25% | cream · topical | FOUGERA PHARMS | Prescription | 29 Jun 2010 |
| DESOXIMETASONE | 0.05% | gel · topical | EPIC PHARMA LLC | Prescription | 10 Mar 2011 |
| DESOXIMETASONE | 0.25% | ointment · topical | FOUGERA PHARMS | Prescription | 28 Sep 2012 |
| TOPICORT | 0.25% | spray · topical | SUN PHARMA CANADA | Prescription | 11 Apr 2013 |
| DESOXIMETASONE | 0.25% | ointment · topical | EPIC PHARMA LLC | Prescription | 24 Apr 2014 |
| DESOXIMETASONE | 0.25% | ointment · topical | PADAGIS ISRAEL | Prescription | 20 Apr 2015 |
| DESOXIMETASONE | 0.25% | cream · topical | SCIEGEN PHARMS | Prescription | 12 Jun 2015 |
| DESOXIMETASONE | 0.25% | ointment · topical | NOVEL LABS INC | Prescription | 10 May 2016 |
| DESOXIMETASONE | 0.05% | gel · topical | RISING | Prescription | 12 Aug 2016 |
| DESOXIMETASONE | 0.25% | ointment · topical | ACTAVIS MID ATLANTIC | Prescription | 7 Nov 2016 |
| DESOXIMETASONE | 0.25% | ointment · topical | RISING | Prescription | 30 Nov 2016 |
| DESOXIMETASONE | 0.25% | ointment · topical | LUPIN | Prescription | 1 Dec 2016 |
| DESOXIMETASONE | 0.05% | ointment · topical | LUPIN | Prescription | 12 Dec 2016 |
| DESOXIMETASONE | 0.05% | cream · topical | SCIEGEN PHARMS | Prescription | 6 Jan 2017 |
| DESOXIMETASONE | 0.25% | cream · topical | LUPIN | Prescription | 9 Jan 2017 |
| DESOXIMETASONE | 0.05% | cream · topical | LUPIN | Prescription | 11 Jan 2017 |
| DESOXIMETASONE | 0.25% | spray · topical | PADAGIS ISRAEL | Prescription | 20 Jan 2017 |
| DESOXIMETASONE | 0.25% | ointment · topical | ZYDUS LIFESCIENCES | Prescription | 19 Sep 2017 |
| DESOXIMETASONE | 0.25% | spray · topical | LUPIN | Prescription | 16 Mar 2018 |
| DESOXIMETASONE | 0.25% | cream · topical | RISING | Prescription | 2 Jul 2018 |
15 more — full table
Canada Canada — marketed products (Health Canada)
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DESOXIMETASONE 0.05% CREAM | $1.50996 | per GM | 23 Sep 2026 |
| US NADAC | DESOXIMETASONE 0.05% GEL | $3.75133 | per GM | 18 Mar 2026 |
| US NADAC | DESOXIMETASONE 0.05% GEL | $3.1892 | per GM | 19 Aug 2026 |
| US NADAC | DESOXIMETASONE 0.05% OINTMENT | $1.02828 | per GM | 23 Sep 2026 |
| US NADAC | DESOXIMETASONE 0.25% CREAM | $0.39788 | per GM | 23 Sep 2026 |
| US NADAC | DESOXIMETASONE 0.25% CREAM | $0.32267 | per GM | 23 Sep 2026 |
| US NADAC | DESOXIMETASONE 0.25% CREAM | $0.44737 | per GM | 23 Sep 2026 |
| US NADAC | DESOXIMETASONE 0.25% OINTMENT | $0.36858 | per GM | 23 Sep 2026 |
| US NADAC | DESOXIMETASONE 0.25% OINTMENT | $0.20004 | per GM | 23 Sep 2026 |
| US NADAC | DESOXIMETASONE 0.25% OINTMENT | $1.05556 | per GM | 23 Sep 2026 |
| US NADAC | DESOXIMETASONE 0.25% SPRAY | $0.648 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 7 Oct 2021 TOPICORT — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.